Practice Valuations Hit Record Highs (And You're Timing This Wrong).

Private equity and DSO buyers paid record multiples in Q4 2024 and January 2025.

A 58-year-old owner who sells at a record multiple this year is not retiring. They're accepting a job offer, a pay cut, and a second unnegotiated deal in the form of rollover equity, and they're doing it because somebody told them multiples peaked. The multiple is the headline. The employment agreement is the invoice.

Here's the claim an informed owner can argue with: the 2026 "record valuation" story is the weakest reason to sell a dental practice right now, and most owners under 60 who transact this year will net less than owners who wait two years and spend that time fixing collections per operatory. The bid for dental practices isn't a cycle you have to catch. It's a structural shift in who owns dentistry, and structural shifts don't close a window on you in eighteen months. What does erode, fast, is your negotiating position once you've already told a buyer you're tired.

The "Record" Number Is Vendor Data, and It's a Range

The figure making the rounds comes from TUSK Practice Sales' Q2 2026 Dental Market Report, which puts headline EBITDA multiples near record levels at 6x to 12x and says 69% of DSOs expect to increase acquisition activity. Worth knowing. Also worth noting that this is sell-side advisory data, not independently audited, and that a range running from 6x to 12x is not a market price. It's a sorting mechanism. Somebody is getting 6x and somebody is getting 12x, and the difference between those two owners has almost nothing to do with what quarter they signed in.

The structural evidence is sturdier. Dentist-owner share of U.S. practices fell to 72.5% in 2023 from 84.7% in 2005, and 16% of dentists were DSO-affiliated in 2024, per the ADA Health Policy Institute. Private-equity affiliation among dentists nearly doubled between 2015 and 2021, from 6.6% to 12.8%, in a peer-reviewed Health Affairs study co-authored by HPI researchers and covered by ADA News. That's a twenty-year reallocation of ownership, not a 2026 event. Capital that has spent a decade building platforms in dentistry does not go home because one year's multiples compress.

Our view: if your entire thesis for selling is "multiples are at the top," you've mistaken a long structural bid for a closing auction, and you're about to negotiate like someone with a deadline against buyers who have none.

What Most Owners Get Wrong: Selling the Top Instead of Selling the Practice

The specific mistake, and it's made most often by solo owners between 55 and 62 with one to three million in collections and no associate, is optimizing the headline multiple while ignoring every other term in the letter of intent. They shop brokers on who promises the biggest number. They let the multiple become the only variable they understand, because it's the only one expressed as a single digit.

Then they sign a document that contains a post-sale employment term of two to three years, a compensation rate set as a percentage of collections rather than their historical owner earnings, a holdback or earn-out tied to performance they no longer control, and rollover equity in a platform whose exit timing belongs to somebody else. Each of those terms moves more money than two points of multiple. Owners negotiate hard on the one and sign the rest as boilerplate.

The second version of the mistake is subtler. Owners sell at the top of a range they were never in. A practice with four producing chairs, a retiring hygienist, 38% of production sitting in two PPO plans, and no documented systems does not get 10x because the market is hot. It gets the bottom of the band, plus a longer earn-out, because the buyer is pricing the work they'll have to do after closing. Market conditions set the ceiling. Your operation sets where you land under it.

925 Practices Are Already Asking

The asking side of the market is crowded and it looks remarkably alike. In the Practice Market Index, our own dataset built from dental practice broker listings, there are 925 practices currently listed for sale. Median collections among listings run $957,588, with the middle half between $650,000 and $1,500,000 (n=753). General practices specifically: median $946,000 (n=644). Median operatory count is 5, middle half 4 to 7 (n=754). Collections per operatory run a median of $200,000, middle half $146,875 to $268,708 (n=643).

These numbers describe practices on the market, not dentistry as a whole, and they say nothing about what any of them will sell for. What they tell you is what a buyer's inbox looks like. If you're a five-chair general practice collecting roughly $950,000, you are not a scarce asset in a hot market. You are the median listing. Hundreds of your lookalikes are sitting in the same pipeline, and the buyer with 69% probability of increasing acquisition volume is choosing among them on something other than vintage.

That something is usually productivity per chair. A five-operatory practice collecting $200,000 per chair is $1,000,000. The same five chairs at $268,708 is $1,343,540. Same real estate, same equipment, same staff core, roughly $343,000 more collections. Being in the top quarter of chair productivity instead of the middle is the difference between competing on price and being competed for.

6x to 9x Is Worth $621,000. The Pay Cut Costs $575,000.

Run it. Hypothetical practice, five operatories, $1,150,000 in collections, four chairs actually producing. Normalized EBITDA after paying a market-rate dentist to do the owner's clinical work lands at 18%, or $207,000.

At the bottom of the reported band, 6x, that's $1,242,000 of enterprise value. At 9x, it's $1,863,000. The spread the owner is fighting over is $621,000. Real money, and it's where every minute of broker conversation goes.

Now price the terms nobody argues about. This owner currently takes $420,000 a year in combined salary and distributions. The post-sale employment agreement pays $190,000 on a production-percentage formula. That's a $230,000 annual pay cut for the two and a half years they're contractually obligated to keep drilling, or $575,000. The entire 6x-to-9x victory, 93% of it, is handed back through a compensation clause that got twenty minutes of attention.

Add 30% rollover equity on the 9x deal, and $558,900 of the purchase price isn't a payment at all. It's an investment in a debt-loaded platform, illiquid, with an exit date set by a sponsor's fund life rather than the owner's 65th birthday. Call it a second deal, negotiated by nobody on the owner's side.

Against that, here's the wait case. Two years spent filling the fifth chair, adding two hygiene days, and moving the worst-paying PPO contract to fee-for-service or out. Collections go to $1,400,000 and margin improves to 22%, because the incremental chair carries fixed costs that are already paid. EBITDA becomes $308,000. Even at a cooler 7x, that's $2,156,000. Compared with selling today at 6x, the owner is ahead $914,000 on enterprise value while having collected two more years of owner income at $420,000 and change.

Multiples would have to fall from 6x to roughly 4x for the wait to lose, and the owner who waits is also negotiating from a stronger operational position, which tends to pull terms in their favor, not just price. We wouldn't take the 2026 deal on those facts. The owner isn't selling at the top of the market. They're selling at the bottom of their own range and calling it timing.

The 68.7 Problem

Average retirement age for U.S. dentists has climbed to 68.7, up from 64.7 in 2001, according to the ADA Health Policy Institute. Four extra working years, on average, across the profession.

That number does two things to the record-valuation story. First, it means the wave of forced sellers that sell-side advisors have been predicting for fifteen years keeps getting pushed out, which is part of why the bid has stayed firm rather than collapsing under supply. Second, and more personally, it means owners selling at 58 because multiples look good are signing up to practice for roughly a decade as somebody's employee. Three of those years are contractual. The rest are the ones they didn't budget for, because the proceeds net of tax, debt payoff, and rollover don't actually fund a 30-year retirement at age 58.

Sell at 58 and you are not exiting dentistry. You're changing who sets your schedule and keeping the handpiece. Plenty of owners genuinely want that: no more HR, no more equipment loans, no more credentialing. Fine. That's a real decision and the multiple is almost irrelevant to it. What's not fine is making that decision while believing it's a market-timing call.

When We'd Actually Sell Into This Market

Three cases, and multiples aren't the driver in any of them. One, the owner is inside three years of genuinely stopping clinical work, in which case terms and payment timing matter enormously and sequencing the sale to the end of a strong collections year is worth real money. Two, the practice has a structural ceiling the owner can't move, meaning a single-doctor building with no room for a fifth chair and a patient base that's already saturated, where two more years of effort won't change EBITDA. Three, the owner has a health or partnership situation that makes the practice a liability rather than an asset, and speed beats price.

Everyone else should treat the 6x-to-12x range as information about how much the gap between a mediocre practice and a tight one is now worth, and go close that gap. Buyers aren't paying a premium for the calendar. They're paying it for chairs that produce, charts that are current, a hygiene department that isn't one resignation from collapse, and a payer mix that doesn't require a 40% write-off to function.

Do This Before You Take Another Broker Call

Pull your last twelve months of collections and divide by your operatory count. If you're under $200,000 per chair, you have a production problem, not a timing problem, and no market condition will price around it. Then ask your accountant for a normalized EBITDA figure that pays a real associate wage for your own clinical hours, because that's the number a buyer underwrites, not your distributions. Last thing: if an LOI is already on your desk, get the employment agreement and the rollover terms priced in dollars before you negotiate a single point of multiple.

If you want a starting point on the valuation side, our free valuation calculator will take your collections, overhead and operatory count and show you where your normalized earnings actually sit before anyone applies a multiple to them. It takes about four minutes. Run your own numbers, then go have the broker conversation knowing which number you're defending.

What we're watching: whether listing volume in the Practice Market Index keeps climbing into 2027, because a crowded asking side plus any cooling in DSO appetite is the one combination that turns a structural bid into a genuine closing window. We'd change our position if PE affiliation data past 2021 shows the growth rate flattening while listings keep rising. That's the setup where selling early is right. It isn't the setup we're in.